Transfusion-dependent Anemia
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00480 | Lenalidomide | A thalidomide derivative used to treat multiple myeloma and anemia in low to intermediate risk myelodysplastic syndrome. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00480 | Lenalidomide | Prostaglandin G/H synthase 2 | target |
| DB00480 | Lenalidomide | Tumor necrosis factor ligand superfamily member 11 | target |
| DB00480 | Lenalidomide | Cadherin-5 | target |
| DB00480 | Lenalidomide | Protein cereblon | target |
| DB00480 | Lenalidomide | P-glycoprotein 1 | transporter |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01609 | Deferasirox | 2 | Completed | 1 |
| DB12281 | Luspatercept | 2 | Recruiting | 1 |
| DB00863 | Ranitidine | 3 | Recruiting | 1 |
| DB00302 | Tranexamic acid | 3 | Not Yet Recruiting | 1 |
| DB12281 | Luspatercept | 4 | Recruiting | 1 |